Related Experiment Video
Updated: Jul 27, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Functional dyspepsia--a multicausal disease and its therapy
1Center for Internal Medicine, Gastroenterology, Hepatology and Metabolism, Klinikum Garmisch-Partenkirchen, Ludwig-Maximilians-University Munich, Auenstrasse 6, 82467 Garmisch-Partenkirchen, Germany. hans.allescher@klinikum.gap.de
Functional dyspepsia, a common gut disorder, involves complex causes affecting the brain-gut axis. Treatments targeting multiple pathways, like STW 5, show promise for symptom relief.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Pharmacology
Background:
- Functional dyspepsia presents with non-specific upper abdominal symptoms unexplained by organic causes.
- It significantly impacts quality of life and incurs substantial socioeconomic costs.
- Etiological theories include motility disorders, acid secretion, visceral hypersensitivity, H. pylori infection, and genetic factors.
Purpose of the Study:
- To explore the multi-causal nature of functional dyspepsia.
- To discuss treatment strategies addressing various symptom generation levels.
- To evaluate the potential of multi-target drugs like STW 5.
Main Methods:
- Review of existing theories on functional dyspepsia etiology.
- Analysis of evidence linking gastrointestinal function to central nervous system processing.
- Discussion of pharmacological approaches targeting different pathophysiological mechanisms.
Main Results:
- Increasing evidence suggests functional dyspepsia is multi-causal, involving altered afferent information processing.
- Autonomic hypersensitivity and altered central processing may be common, exacerbated by factors like motility changes or inflammation.
- Various treatments (anti-secretory, prokinetic, anti-inflammatory) show symptomatic responses.
Conclusions:
- Functional dyspepsia management should address multiple levels of symptom generation.
- Multi-target agents like STW 5 offer a logical therapeutic approach.
- Further research is needed to confirm the superiority of combination therapies.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Complications

